Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease

ConclusionAlthough ILD was associated with a higher incidence of pneumothorax, the efficacy of LAT for NSCLC patients with ILD was comparable to those without ILD, suggesting that LAT might be a reliable and effective treatment option for this population, particularly in the early stage.

Source: Thoracic Cancer - February 24, 2024 Category: Cancer & Oncology Authors: Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Fei Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren Tags: ORIGINAL ARTICLE Source Type: research